50 employees
Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.
2007
$30M
from 5 investors over 5 rounds
Virdante Pharmaceuticals raised $30M on November 25, 2009
Investors: Thomas, McNerney & Partners, Venrock, Clarus Ventures, LLC, Osage University Partners (OUP) and Biogen Idec